U.S. Consumer Finance Stock News

Wondering whether HubSpot's current share price lines up with its underlying value, or if the recent weakness has opened up an opportunity for you? HubSpot now trades at US$245.14 after a 3.1% gain over the last 7 days, set against a 17.3% decline over 30 days and a 35.9% drop year to date, with a 50.8% slide over the past year. These moves sit against a backdrop of ongoing interest in software and customer relationship tools, with investors weighing how much they are prepared to pay for...

If you are wondering whether Lam Research's share price still lines up with its fundamentals, the starting point is to understand what the recent market action might be implying about value and risk. Over the most recent periods, the stock has posted returns of 10.4% over 7 days, 10.7% over 30 days, 19.2% year to date, 257.3% over 1 year and 347.6% over 3 years, with a 5 year return of 257.9%. Recent headlines around Lam Research have kept attention on the stock, with investors closely...

Investors may be wondering whether Haemonetics at US$58.46 is starting to look interesting on value, or if the market is still unsure what it is worth. The stock has returned 6.4% over the last 7 days, while the 30 day and year to date returns are an 8.8% decline and a 26.9% decline. The 1 year return is a 0.8% decline and the 3 year and 5 year returns are a 30.2% and 49.9% decline. These mixed returns have kept attention on how the market is pricing Haemonetics and what is driving investor...

Event context and recent performance snapshot Cullen/Frost Bankers (CFR) has attracted renewed attention after recent share price moves, with the stock showing positive returns over the past week, month, and past 3 months, as well as over the past year. That price action sits alongside reported annual revenue of US$2,191.0 million and net income of US$635.5 million. These figures give investors a current reference point as they weigh the bank’s valuation and long run track record. See our...

Wondering if Kulicke and Soffa Industries at about US$66.62 is priced for its recent momentum or leaving some value on the table? This breakdown will help you frame that question clearly. The stock has posted returns of 7.8% over the past week, 8.4% over the last month, 37.8% year to date and 132.2% over the past year, which can change how the market views both its potential and its risks. Recent coverage has focused on how semiconductor related names like Kulicke and Soffa Industries fit...

If you are wondering whether Teekay Tankers at around US$78.21 is still offering value or has already priced in the story, the key is to understand what current valuation signals are really saying about the stock. The share price has moved recently, with returns of 8.6% over the last 7 days, 8.9% over the last 30 days, 51.9% year to date, 116.8% over 1 year, 128.7% over 3 years, and a very large gain over 5 years. Recent news has focused on Teekay Tankers as an established player in the oil...

EQT (EQT) has upsized its cash tender offer to repurchase up to US$1.4b of outstanding senior notes, after strong early bondholder participation signaled active reshaping of the company’s debt profile and credit mix. See our latest analysis for EQT. The tender offer sits against a mixed share price backdrop, with a 1 day share price return of 1.17% and a 7 day share price return showing a 6.27% decline. The 90 day share price return of 13.09% and 1 year total shareholder return of 29.18%...

AeroVironment recently announced that it was selected by the U.S. Navy to compete for Contractor-Owned, Contractor-Operated ISR services using its JUMP 20-X VTOL drone platform, while also unveiling its third-generation LOCUST X3 high-energy laser system for counter‑drone defense. These advances in autonomous ISR and AI-enabled laser weapons arrive as the company faces legal scrutiny and financial pressure linked to a Space Force program stop‑work order and goodwill impairment. We’ll now...

BioCryst Pharmaceuticals recently appointed Sandeep M. Menon, MD, PhD, as Chief Research and Development Officer, bringing experience from senior R&D leadership roles at Alnylam Pharmaceuticals and Pfizer, where he oversaw global clinical development and multiple FDA approvals. His background in biostatistics, clinical development and rare disease programs could influence how BioCryst advances its pipeline beyond ORLADEYO and manages R&D execution risk. We’ll now examine how Dr. Menon’s...

If you are wondering whether TJX Companies at around US$161.82 is offering good value today, it helps to separate the share price story from what the underlying business might be worth. The stock has shown solid returns recently, with 3.9% over 7 days, 1.6% over 30 days, 4.9% year to date, 37.5% over 1 year, 115.0% over 3 years and 150.4% over 5 years. This naturally raises questions about how much future upside or downside is already reflected in the price. Recent coverage has focused on...

Senior executives at Public Service Enterprise Group (NYSE:PEG), including CEO Ralph Larossa and Senior Vice President Richard T. Thigpen, recently reported multiple insider stock sales. These transactions add to a series of insider sales at NYSE:PEG over the past year, with no insider purchases disclosed in the same period. The activity focuses attention on executive ownership levels and how leadership is managing personal exposure to company stock. Public Service Enterprise Group operates...

The United States market has shown robust performance, climbing 4.4% in the last week and gaining 32% over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying small-cap stocks that are undervalued and exhibit insider buying can offer intriguing opportunities for investors looking to capitalize on potential growth.

The United States market has experienced a notable upswing with a 4.4% increase over the past week and a substantial 32% rise in the last year, while earnings are projected to grow by 16% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors opportunities for growth, as they look for companies like Kratos Defense & Security Solutions that have strong fundamentals yet remain undervalued by the market.

The United States market has experienced a robust performance recently, climbing 4.4% in the last week and rising 32% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company’s operations and potential for sustained growth.

The market has shown impressive performance recently, with a 4.4% increase over the last week and a 32% climb in the past year, while earnings are anticipated to grow by 16% annually. For investors interested in smaller or newer companies, penny stocks—though an outdated term—continue to offer intriguing opportunities for value and growth. By focusing on those with solid financial foundations, these stocks have the potential to provide both stability and long-term potential.

The United States market has experienced a robust performance, climbing 4.4% over the last week and 32% in the past year, with earnings anticipated to grow by 16% annually in the coming years. In this dynamic environment, identifying promising small-cap stocks can be key for investors seeking opportunities that align with these positive trends.

The United States market has experienced a robust performance recently, climbing 4.4% in the past week and 32% over the last year, with earnings anticipated to grow by 16% annually in the coming years. In this dynamic environment, dividend stocks like Independent Bank can offer investors a blend of income and potential growth, making them an attractive option for enhancing portfolios.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

NeuroOne Medical Technologies Corporation ( NASDAQ:NMTC ) insiders who purchased shares in the last 12 months were...

Insiders who purchased US$50.0k worth of The Children's Place, Inc. ( NASDAQ:PLCE ) shares over the past year recouped...

Mondelez International (MDLZ) is back in focus after quarterly results topped expectations and several research firms reiterated positive ratings, highlighting the snack giant’s global reach, renewed attention on emerging markets, and increased brand investment. See our latest analysis for Mondelez International. At a share price of US$58.38, Mondelez has delivered a 10.71% 90 day share price return, even as the 1 year total shareholder return sits at a 7.52% decline. This suggests recent...

Biogen (NasdaqGS:BIIB) has agreed to acquire Apellis Pharmaceuticals, adding two commercial immunology and rare disease products to its portfolio. The company has received FDA approval for a High Dose Regimen of SPINRAZA for spinal muscular atrophy, based on pivotal trial data in infants. Both moves expand Biogen's presence in neurology and rare diseases, with implications for its pipeline mix and revenue sources. Biogen is known for its focus on neurology and rare diseases, and the Apellis...

Suburban Propane Partners, L.P. recently announced that it expanded its partnership with NASCAR to cover 21 tracks, including the NASCAR event at Naval Base Coronado in California and a renewed presence at Chicagoland Speedway, supporting race operations, concessions, and campgrounds behind the scenes. This broadened NASCAR footprint highlights Suburban Propane’s role as a key energy provider for large live events, aligning its brand with high-visibility sports and national celebrations like...

Constellation Energy Corp. disclosed that Board member Alan Armstrong resigned on March 23, 2026, as the company continues integrating its recently closed Calpine acquisition and executing required asset sales in the PJM market. These developments highlight how Constellation is reshaping its generation mix to serve AI data center demand while managing regulatory constraints and interconnection delays. We’ll now explore how Constellation’s Calpine acquisition and related asset divestitures...